InvestorsHub Logo
Followers 29
Posts 2503
Boards Moderated 0
Alias Born 04/09/2010

Re: Biorunner post# 36364

Monday, 12/13/2010 6:30:55 PM

Monday, December 13, 2010 6:30:55 PM

Post# of 97239
Yes. Also heard good points. There are conflicting news reports out. Some reports say they were favorable treatment differences observed for KEY secondary pain endpoints. Other reports say shingles drug fails in mid-stage trial. It sounded more positive to me than negative. OB nailed it with "the sizzle got ahead of the steak". I'm still long INHX>

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.